Kezar Life Sciences, Inc. (KZR) Net Equity Issued and Repurchased (2018 - 2022)

Kezar Life Sciences has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $77.9 million in Q2 2022.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $77.9 million in Q2 2022, while the trailing twelve-month figure through Dec 2022 was $126.5 million (changed N/A YoY) and the FY2022 annual result came in at $126.5 million, up 25.25% from the prior year.
• Net Equity Issued and Repurchased rose to $77.9 million in Q2 2022 per KZR's latest filing, from $48.6 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $77.9 million in Q2 2022 and troughed at -$1.1 million in Q3 2018.